Core Viewpoint - KQ Bio (688526.SH) reported its 2025 semi-annual results, highlighting a significant presence of institutional investors in its shareholding structure [1] Institutional Investors - As of August 25, 2025, four institutional investors disclosed holdings in KQ Bio, totaling 80.6962 million shares, which represents 17.31% of the company's total share capital [1] - The institutional investors include Wuhan Huazhong Agricultural University Asset Management Co., Hong Kong Central Clearing Limited, Qianhai Kaiyuan Xianghe Bond A, and Qianhai Kaiyuan Yuru Mixed A [1] - Compared to the previous quarter, the total institutional holding percentage increased by 0.47 percentage points [1] Public Funds - During this period, two new public funds were disclosed compared to the previous quarter, namely Qianhai Kaiyuan Xianghe Bond A and Qianhai Kaiyuan Yuru Mixed A [1] - Two public funds were not disclosed in this period compared to the previous quarter, which are Huian Core Asset Mixed A and Chuangjin Hexin Quantitative Multi-Factor Equity A [1]